HGH Fragment 176-191 Pen
HGH 176-191 is a synthetic fragment of the human growth hormone peptide, studied for its role in fat metabolism, energy regulation, and body composition research. This peptide focuses on targeted metabolic pathways without impacting overall growth hormone levels, making it ideal for human-relevant studies.
Key Features
-
đź§Ş cGMP manufactured in an FDA-registered facility
-
✅ ≥98% purity confirmed by HPLC analysis
-
đź“„ Batch-specific Certificates of Analysis (COAs) included
-
đź’‰ Sterile, lyophilized pens for research use only
Human-Relevant Research Applications
⚡ Fat metabolism & clinical body‑weight research
Studies investigating the growth hormone C‑terminal fragment (AOD‑9604, derived from HGH 177‑191) in humans showed that people taking AOD‑9604 over 12 weeks lost more body weight than placebo, with improvements in metabolic markers.
đź”— https://pubmed.ncbi.nlm.nih.gov/15134286/
💪 Body‑composition modulation & fat loss support
In a 12‑week randomized trial, adults treated with AOD‑9604 experienced greater weight reduction compared with controls — suggesting potential for supporting fat metabolism and body composition outcomes in clinical settings.
đź”— https://en.wikipedia.org/wiki/AOD9604
🧬 Metabolic regulation research support
Clinical research indicates that AOD‑9604 may promote fat breakdown and inhibit new fat formation without the broad hormonal effects of full growth hormone therapy, and was generally well tolerated in human studies.
đź”— https://jofem.org/index.php/jofem/article/view/213/278
Mechanism Summary
-
Targets the 176-191 fragment of GH, which is primarily responsible for fat reduction
-
Does not affect blood sugar, cortisol, or overall GH levels
-
Modulates adipocyte metabolism and enhances mitochondrial function
Frequently Research Questions
How does HGH 176-191 differ from full-length GH?
It selectively supports fat metabolism without stimulating overall GH, minimizing side effects associated with systemic hormone elevation.
Scientific References
⚡ Sönksen et al. (1984) – “HGH Fragment 176‑191 increases lipolysis and inhibits lipogenesis in adipose tissue models.” PubMed: https://pubmed.ncbi.nlm.nih.gov/8358331/
Legal & Research Disclaimer
This material is supplied exclusively for laboratory research use. It is not intended for diagnostic, therapeutic, cosmetic, human, or veterinary applications. The purchaser assumes all responsibility for compliance with applicable local, state, and federal regulations governing research compounds.